Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ganciclovir bulk supplier for pharma manufacturers

Ganciclovir 250 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 250 mg

Reference Brands: Cytovene®(EU & US)

Category: Anti Viral

Ganciclovir Capsules 250 mg are used to treat CMV infections in immunocompromised individuals. Though largely replaced by valganciclovir in developed markets, these capsules remain in use for cost-effective antiviral therapy. Available via PharmaB2B from WHO-GMP suppliers for tenders, hospitals, and public health programs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Ganciclovir Capsules 250 mg are antiviral medications used in the treatment and prevention of Cytomegalovirus (CMV) infections in immunocompromised patients, including those with HIV/AIDS or undergoing organ transplants. Though less commonly used today due to the availability of valganciclovir, Ganciclovir remains valuable in cost-sensitive markets. Available in capsule form, it is manufactured by WHO-GMP certified pharmaceutical companies and offered through PharmaB2B platforms for bulk purchasing, hospital procurement, and tender supplies. Ganciclovir Capsules offer a cost-effective solution for CMV management where oral antiviral therapy is needed and budget constraints are a concern.

Ganciclovir — third party manufacturing & bulk supply

Ganciclovir 250 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Ganciclovir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Ganciclovir →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ganciclovir is an antiviral medicine used to treat and prevent cytomegalovirus (CMV) infections, especially in immunocompromised patients such as those with HIV/AIDS or transplant recipients. It helps control viral replication and reduces the risk of CMV-related complications.

Ganciclovir is made from a synthetic nucleoside analogue that inhibits viral DNA polymerase, preventing the virus from multiplying.

Common trade names include Cymevene and Cytovene.

Ganciclovir (Cytovene/Cymevene) has been produced by Roche, while many global pharmaceutical companies manufacture generic versions.

The generic name is ganciclovir.

Brand names include Cymevene and Cytovene, with additional generic brands available worldwide.

Ganciclovir is manufactured in multiple regions, including India, Europe, and the USA, by licensed pharmaceutical manufacturers.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.